Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Analyzing the Health Effects of Space Travel with AI

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke  with host Tyler Kern about the movement collaboration…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Space is a frontier for global innovation, but space doesn’t come without its limits. As exploration grows, the importance of human health in outer space grows as well. Shashi Jain, Senior Strategic Innovation Manager at Intel, and Dr. John Kalantari, Chief Technology Officer at Yrikka, Inc. spoke with host Tyler Kern about the movement collaboration between Intel and the Frontier Development Lab an applied artificial intelligence research accelerator established to maximize new AI technologies and capacities emerging in academia and space and exploration.

The Intel and Frontier Development Lab collaboration aims to improve the data collection of astronauts. The collaboration is working to make space exploration safer and healthier through artificial intelligence. “The collaboration with Intel rose organically. We were already applying AI and machine learning in the space, specifically for decision making,” says Dr. Kalantari.

“AI, when it comes to terrestrial medicine, is suffering from the same challenges as astronaut health and space medicine,” says Dr. Kalantari, who believes part of the issue is combining the health data of astronauts safely and securely into one database. “To train an AI, you have to bring together all the data into one spot and use that to train the algorithms,” says Shashi Jain.

The risk of spending time in space is detrimental to the human body. According to NASA, when astronauts are in microgravity, the human body loses muscle mass and bone density. Physically and psychologically, the impact on human bodies could be detrimental. The mission could fail if health issues hinder a crew member on a mission.

Currently, the effects on astronauts are similar to how we gather health information on earth. Data is collected through observation and measuring vitals. “We use this collection of data before, during, and after each mission to identify any prominent biomarkers that could be indicators of disease progression,” says Jain. The main challenge of the project is maintaining the privacy of the individuals so that the collected data can train AI for the future.

For more information on the power of technology and the future of astronaut health, connect with Shashi Jain and Dr. John Kalantari on LinkedIn or explore Intel’s Health and Life Sciences page.

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Network & Edge Solutions Group.

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Dental practice exits are turning into multi-year projects, not last-year decisions

Dental practice exits are turning into multi-year projects, not last-year decisions

Associate-led dental practice successions can take 3–5+ years. Dental Economics says associate-to-buyout timelines often run three to five-plus years. That pushes revenue-cycle controls, buy-sell terms, and tax structure earlier, before a buyer appears.

  • 01A practical benchmark is emerging for succession: bringing in an associate with intent to buy can take a minimum of three years and often more than five, according to Dental Economics.
  • 02If accounts receivable looks “high,” it may be a bookkeeping and posting problem before it is a payer problem, a revenue-cycle diagnostic Group Dentistry Now says shows up frequently at scale.
  • 03Exit planning is now an operating system project: valuation, tax positioning, and transition support belong in the same workstream, because deal structure can lock in or foreclose tax options, per Dental Economics.

Sep 4, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512